Following media reports yesterday, AstraZeneca today confirmed it has voluntarily paused phase 3 trials of the COVID-19 vaccine developed with Oxford University so that an independent committee can investigate an unexplained illness in a UK participant.In other global COVID-19 developments, the world neared the grim milestone of 900,000 deaths.
So far, pandemic cases have reached 27,683,499, and 899,808 people have died from their infections, according to the Johns Hopkins online dashboard.Experts says vaccine pause not surprisingAstraZeneca said the pause and investigation are standard whenever there is an unexplained illness, which can happen by chance in large clinical trials.